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Abstract The impact of uncoupling protein (UCP) 1, UCP3
and UCP3s expressed in yeast on oxidative phosphorylation,
membrane potential and H+ transport is determined. Intracel-
lular ATP synthesis is inhibited by UCP3, much more than by
UCP1, while similar levels of UCP3 and UCP1 exist in the
mitochondrial fractions. Measurements of membrane potential
and H+ efflux in isolated mitochondria show that, different from
UCP1, with UCP3 and UCP3s there is a priori a preponderant
uncoupling not inhibited by GDP. The results are interpreted to
show that UCP3 and UCP3s in yeast mitochondria are in a
deranged state causing uncontrolled uncoupling, which does not
represent their physiological function. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Uncoupling proteins (UCP) are supposed to uncouple oxi-
dative phosphorylation [1]. They are localised in the inner
mitochondrial membrane and there rechannel H pumped
by the respiration chain. Whereas this concept is experimen-
tally well established for UCP1 in brown adipose tissue, for
the UCP variants occurring in other tissues, UCP1^4 and
BCMP-1 [2], convincing experimental evidence for their func-
tion as H transporters is lacking despite recent claims to the
contrary, as will be discussed below. One reason is the low
abundance of these new UCP variants in their respective tis-
sues whereas UCP1 could be isolated in high amounts from
brown adipose tissues. Therefore the need for heterologous
overexpression for the UCP variants was even more impor-
tant than for UCP1.
For the recombinant expression of the UCPs, Saccharomy-
ces cerevisiae has been a preferred host. First UCP1 from
brown adipose tissue was introduced into yeast cells and
was quite abundantly incorporated in yeast mitochondria,
without negatively in£uencing the growth of the yeast cells
[3^6]. This expression system was extensively used as a vehicle
for elucidating the structure^function relationship in UCP1 by
directed mutagenesis [6^13]. Following this lead, the discov-
eries of UCP variant genes, UCP2, UCP3 and BCMP [14^19],
also initiated their expression in S. cerevisiae [17^21]. The
uncoupling was measured by £uorescent activating cell sorting
(FACS) using a £uorescent probe for the mitochondrial mem-
brane potential. In yeast cells expressing UCP2 and 3, a stron-
ger decrease of membrane potential was reported than in cells
expressing UCP1 [17^19]. However, it cannot be decided a
priori whether the observed downshift of the £uorescence
maximum in the FACS pro¢le is caused by a decrease of
the membrane potential, i.e. an uncoupling e¡ect, or merely
by a decrease of the amount of mitochondria [19]. Further the
uncoupling function of UCP2 and UCP3 was investigated at
the level of isolated mitochondria from yeast [20^24]. Also
with UCP1 and UCP3 reconstituted from inclusion bodies
in Escherichia coli no [25] or only a low and barely nucleo-
tide-sensitive H transport was obtained [26]. In our view, the
emerging picture of UCP3 function is far from clear if one
applies rigorous criteria for uncoupling protein such as a regu-
lated H transport.
Here we scrutinise the uncoupling and the H transport by
UCP3 expressed in yeast using experimental approaches not
yet applied. As a reference we use the well studied UCP1
expression in yeast cells. At variance with other authors we
conclude that, di¡erent from UCP1, UCP3 and UCP3s incor-
porated into yeast mitochondria exist largely in a deranged
and non-physiological state which allows uncontrolled H
transport. Only traces of UCP3 are in the native conforma-
tion with regulated uncoupling.
2. Materials and methods
The gene for UCP1 for hamster was cloned in the pEMBL Lyex4
vector under the control of the gal 10-cy1 promoter as described [11].
Similarly the gene for human UCP3 and of UCP3s was introduced
into this vector. Further full-length coding sequences of human UCP3
and UCP3s were cloned into the vector pYES2 (Invitrogen) as de-
scribed previously [27]. They were also cloned into the BglII restric-
tion enzyme site of the high expression vector pGAL110 [28].
Yeast cells were grown in selective lactate medium with 0.67% yeast
nitrogen base, 2% lactic acid, 0.05% glucose, with amino acids and
adenine at 40 mg/l each, pH 5.5. Galactose was added to a ¢nal
concentration of 0.4% at 11 h after start of the culture. Mitochondria
were isolated as described [11].
Oxidative phosphorylation in yeast cells was measured according to
a method used for yeast cells carrying mutant ADP/ATP carrier [29].
In brief, cells were starved by aeration. To deplete ATP the washed
cells were made anaerobic by £ushing with N2 under addition of 1%
ethanol for 30 min. ATP synthesis was started by bringing the sus-
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pension in a thermostated (10‡) syringe and with fast stirring under
O2 ; aliquots were withdrawn typically after 10, 20, 30, 60 and 120 s
and extracted with HClO4 for the enzymatic ATP determination.
Mitochondria were isolated from yeast cells according to the pro-
cedures speci¢ed previously [11,30]. Spheroplasts from yeast cells were
generated as for the isolation of mitochondria and permeabilised by
nystatin according to [31]. For the immunoblots of mitochondria,
polyclonal antibodies were used, raised in rabbits against whole
UCP1 and against the 14 residue long peptide of UCP3
S149IHLGPSRSDRKYS162.
Measurements of membrane potential in mitochondria were per-
formed with the £uorescent cyanine dye 3,3P-dipropylthiacarbocya-
nine (disC3) obtained from Molecular Probes. A highly sensitive £u-
orometer constructed in our workshop was used, with internal stirrer
and a quartz ¢bre conducting the emitted light directly from the
cuvette to the photomultiplier which had a special red-sensitive photo-
cathode S22. Exciting light was at 620 nm, emitting light with a cuto¡
¢lter RG 645 (Schott) at s 650 nm. For stabilising the signal, part of
the incident light was diverted by a beam splitter and monitored by a
photodiode which regulated the dynode voltage of the measuring
photomultiplier for compensating the light £uctuations of the xenon
arc lamp. Mitochondrial H in£ux was measured according to the
previously detailed procedure [12].
3. Results
UCP3 was introduced into yeast cells by various vectors
which employ the galactose promoter. Besides the normal
(‘long’) form of UCP3 (UCP3), the short spliced variant
UCP3s was expressed in which the last 37 residues of UCP3
are omitted [28]. Fig. 1 shows that induction of human
hUCP3 and hUCP3s decreases the growth rate. As a control
we used cells with the ‘empty’ pYES2 vector. The generation
time with pYES2 is only 3.1 h, with pYES2^hUCP3 5.4 h,
and with pYES2^UCP3s 4.9 h. Other variations of the cell
growth were tested, such as changing the carbon source to
ra⁄nose, varying the induction time and the amount of in-
ducing galactose. Whereas the growth rate and expression
levels changed, there was no principal change of those proper-
ties of the UCP3-containing cells and mitochondria, which are
characterised in the following.
The content of UCP in the mitochondrial fraction was as-
sayed by immunoblots. In Fig. 2 the levels of UCP1 and
UCP3 in the expression vectors pEMBLyex4 and pYES2 are
shown. The UCP1 antiserum was generated in rabbits against
hamster UCP1 and the UCP3 antiserum against a peptide of
14 residues localised on the matrix side of the second domain.
Di¡erent antisera had to be used for UCP1 and UCP3 since
there was no cross-reaction. The blots give a semi-quantitative
picture of the UCP3 content in the various preparations.
Interestingly, the content of UCP3s reaches a higher level
than of UCP3. The expression can be increased by using min-
imal nitrogen base medium instead of ‘full’ medium for UCP3
and UCP3s, as noted previously for the expression of UCP1
[11]. The immunoblot also displays the higher UCP3 content
with the very high expression vector pGal110. Whereas the
immunostain of UCP1 can be ‘calibrated’ through the binding
of nucleotides, this is not possible for UCP3 in yeast mito-
chondria, due to the lack of GDP binding and the di¡erent
antibodies required for UCP1 and UCP3. The immunostain
of UCP3 could be semi-quantitatively evaluated by compar-
ison with UCP3 expressed in E. coli in inclusion bodies (not
Fig. 1. The growth curves of yeast cells transfected with human
UCP3 and with the short form hUCP3s. Aerobic growth in minimal
nitrogen base medium with lactate as carbon source. Cells from a
preculture were added to 600 ml of the standard medium (see Sec-
tion 2) in culture £asks. Expression is induced by addition of 0.5%
by weight ¢nal concentration of galactose at 11 h after start of the
culture.
Fig. 2. Immunoblots of mitochondria isolated from UCP-transfected
yeast cells. Comparison of various expression vectors (pEMBL,
pYES2 medium high expression, pGal110 very high expression). For
haUCP1 rabbit antiserum against whole hamster UCP1 was used,
for UCP3 and UCP3s antiserum against a 14 residue peptide (see
Section 2). 40 Wg mitochondrial protein was added to each lane.
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shown) estimating the UCP3 protein content up to about 1^
5% for UCP3 in the three vectors, and 2^10% for UCP3s in
the two vectors. This compares with about 2% UCP1 in yeast
mitochondria [11].
3.1. Oxidative phosphorylation in cells
The e¡ect of the overexpressed UCPs on oxidative phos-
phorylation was directly assayed by measuring the ATP syn-
thesis in yeast cells according to a previously described pro-
cedure [29]. For an accurate assessment the time progress of
ATP synthesis was followed after initiating oxidative phos-
phorylation by addition of oxygen to the anaerobic yeast cells.
The initial rates of ATP synthesis are a quantitative measure
of the oxidative phosphorylation capacity (Fig. 3). In cells
expressing hamster haUCP1, the phosphorylation rate is
only 20% lower than in the parent strain. However, in cells
expressing human hUCP3 the activity is reduced by 70%.
Di¡erently, with the expression of murine mUCP3 the oxida-
tive phosphorylation is only inhibited by 32%.
3.2. Membrane potential measurements in mitochondria
Recording of the mitochondrial membrane potential v8
with the £uorescent probe disC3 provides a highly sensitive
method for assessing the uncoupling by UCP. Very small
amounts of mitochondria can be used. The method can also
be applied to permeabilised spheroplasts [31]. As a reference
the recording of v8 with yeast mitochondria containing
haUCP1 is shown (Fig. 4A). On addition of the substrate 1-
glycerophosphate (GP), v8 strongly increases and on addi-
tion of lauric acid (LA) it drastically falls. GDP fully reverses
the uncoupling e¡ect of LA. To establish as a control the
uncoupled state, valinomycin was added which collapses the
v8 by facilitating the in£ux of external K. The uncoupler
carbonylcyanide m-chlorophenylhydrazone (CCCP) cannot be
used since its absorption interferes with the £uorescence of
disC3. With prior addition of GDP (not shown), LA produces
only a short transitory decrease of v8 which responds to the
uptake of undissociated LA and the accompanying internal
pH decrease.
In mitochondria from cells expressing human hUCP3, on
addition of GP v8 develops more slowly than with haUCP1
mitochondria. LA decreases the v8 only by 20% and with
GDP a minor increase is observed, followed by the slow £uo-
rescence increase evident before the addition of LA. On prior
addition of GDP, the GP-induced v8 increase becomes faster,
indicating a minor GDP-sensitive recoupling. However, the
small fatty acid-induced uncoupling is not prevented. In mi-
tochondria from cells containing the ‘empty’ pYES2 vector a
somewhat smaller decrease of v8 by LA is measured, which is
GDP-insensitive. This v8 has to be subtracted from that ob-
served in the UCP3-containing mitochondria. As a result the
GDP-sensitive v8 decrease attributable to native UCP3
amounts to only about one tenth of that observed with
UCP1. In mitochondria with the short form hUCP3s, the
addition of 50 WM LA induces a small v8 increase which
may be due to a turbidity decrease of the mitochondria.
The ‘non-speci¢c’ GDP-insensitive uncoupling by 100 WM
LA is observed as a rule in all yeast mitochondria, independ-
ent of the transfection with UCP. In summary, due to the
high a priori uncoupling, the induction of uncoupling by fatty
acid in UCP3-containing mitochondria is much smaller than
with UCP1 and largely unregulated, i.e. with only traces of
GDP-induced recoupling.
With spheroplasts generated from the yeast cells and per-
meabilised by nystatin [31] or by osmotic shock, it was also
possible to record the v8 with the £uorescent probe (Fig. 4B).
An advantage is that the isolation of mitochondria from yeast
cells, with their notoriously low yield, can be bypassed. In
spheroplasts mitochondria are still in a more native environ-
ment which may modify the UCP response. As shown in Fig.
4, in spheroplasts containing haUCP1 the response of v8 to
GP was as strong as in isolated mitochondria. LA and the
non-metabolisable 2-Br-palmitate produced strong uncou-
pling, which was fully reversed by GDP. In spheroplasts con-
taining hUCP3 a small uncoupling was produced only after
addition of 100 WM LA. The response was much smaller than
with UCP1, similar to that in mitochondria. This uncoupling
was insensitive to GDP.
3.3. H+ transport
Another assay for UCP function in mitochondria is the
direct measurement of H transport [12]. To this purpose
mitochondria are incubated with 100 mM KCl and 50 WM
LA. The H pumping by electron transport is suppressed by
antimycin. During the preincubation with KCl, ¢rst Cl3 is
taken up via UCP followed by a H in£ux and as a result
mitochondria become more acidic inside, which is a prereq-
uisite for the observed H e¥ux in exchange for K in£ux.
On addition of valinomycin the K uptake causes a v8 pos-
itive inside which drives H outside through UCP. The rec-
ords in Fig. 5 compare the H e¥ux in mitochondria con-
Fig. 3. Oxidative phosphorylation in yeast cells. Inhibition by the
plasmid-mediated expression of UCP1 and UCP3. Yeast host cells
(W303) and cells transformed with hamster haUCP1, human
hUCP3 and murine mUCP3. The oxidative phosphorylation is mea-
sured as the rate of ATP formation after addition of O2 and etha-
nol to anaerobic, starved cells. For details see Section 2.
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taining haUCP1 and hUCP3. A small but distinct H e¥ux
can be induced in hUCP3-containing mitochondria, which is
largely suppressed on preincubation with 100 WM GTP. This
e¡ect is observed only in mitochondria from cells, when
hUCP3 expression is induced by lower amounts of galactose
and shorter growth time. The experiment shows that expres-
sion of hUCP3 can confer on the mitochondria a nucleotide-
sensitive H transport, which is, however, much weaker than
with UCP1. With mitochondria containing UCP3s, no fatty
acid- and nucleotide-sensitive H import was detected (results
not shown).
3.4. Nucleotide binding
The binding of nucleotides has been the most important
assay for the intact functionality and for the quanti¢cation
of UCP1 [13]. Radiolabelled and £uorescent nucleotides
have been extensively used to measure the nucleotide binding
to UCP1 expressed in yeast [1]. In contrast, all attempts to
detect binding to mitochondria from cells expressing hUCP3,
mUCP3 and hUCP3s failed, both with [14C]GTP and with
dansyl GTP. The limit of detection is at about 0.1 Wmol/mg
mitochondria.
4. Discussion
Because of the successful expression of functional UCP1 in
S. cerevisiae, this expression system seemed to be the obvious
choice for UCP3 as for the other UCP variants. UCP3 can
reach the same expression levels as UCP1, depending on the
expression system used. The short form UCP3s is expressed to
an even higher extent. Di¡erent from UCP1, the expression of
UCP3 in yeast cells signi¢cantly decreased growth and caused
Fig. 4. A: Recording of membrane potential (v8) with the £uorescence dye disC3 in mitochondria containing various UCPs, UCP1, UCP3
and UCP3s (short form). The two expression vectors used are given in brackets. 6 Wg mitochondrial protein was added to a ¢nal volume of
400 Wl. B: Recording of v8 with the £uorescent dye disC3 in permeabilised spheroplasts (S) derived from yeast cells overexpressing UCP1 and
UCP3 (see Section 2). 38^40Wg spheroplasts was added to a total volume of 400 Wl.
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some uncoupling. However, a convincing functional charac-
terisation of UCP3 in cells and isolated mitochondria was not
achieved [22^24], as we will explain in the following.
4.1. UCP3 in yeast cells
The test of uncoupling function at the cellular level by the
direct determination of intracellular ATP synthesis shows only
a small decrease with UCP1, but with human hUCP3 inhibi-
tion of oxidative phosphorylation up to 80% is found. The
results are in agreement with the decrease of the £uorescence
in the FACS scans of yeast cells on expression of UCP3 and
of UCP3s [14,17]. However, the interpretation of the FACS
shift is not unique since it can also be caused by fewer mito-
chondria in the UCP3-expressing cells [19]. Probably both
partial uncoupling and a resulting decreased mitochondrial
biogenesis contribute to the observed e¡ects. The FACS scans
in UCP1-expressing cells vary among the reports. Whereas
Gong et al. [17] and Boss et al. [15] found a low £uorescence
change in FACS by UCP1, in accordance with our oxidative
phosphorylation measurements, Zhang et al. [20] reported the
same strong shift as with UCP3. Also thermogenesis has been
reported to be increased by about 30% in UCP3- but less in
UCP1-expressing yeast [32]. The more drastic e¡ect of UCP3
on ATP synthesis than on intracellular £uorescence and ther-
mogenesis (80% inhibition of oxidative phosphorylation ver-
sus 30% shift of FACS) can be rationalised by the high sensi-
tivity of oxidative phosphorylation towards the decrease of
v8 in mitochondria.
4.2. UCP3 in isolated mitochondria
The recording of v8 in mitochondria by a £uorescent
probe is a more sensitive method to assess the uncoupling
characteristics of UCP than respiration. Yeast mitochondria
containing UCP1 provide a ‘master’ pattern of strong v8
responses to the activators and inhibitors, to which the
UCP3-containing mitochondria have to be compared. Already
the initial increase of v8 by substrate addition to UCP3-con-
taining mitochondria is more subdued than with UCP1, re-
£ecting a fatty acid-independent uncoupling. Only a barely
discernible, GDP-sensitive uncoupling induced by fatty acid
can be observed occasionally. With the short form, UCP3s,
the GDP-sensitive uncoupling is completely absent. Similarly,
direct measurements of H transport show only a small GDP-
sensitive H release in mitochondria containing UCP3 but
none with UCP3s. The very low share of a fatty acid-inducible
and nucleotide-sensitive uncoupling as probed by v8 and by
H transport, which are the hallmarks of UCP1 function, is
remarkable in view of the high content of UCP3 in the mito-
chondria.
By measuring respiration of mitochondria from UCP3-ex-
pressing yeast cells, both groups [20^22,24] found an increased
uncoupling which was insensitive to inhibition by nucleotides.
Fatty acids stimulate respiration of mitochondria from UCP3-
expressing yeast cells only very poorly, if at all. The authors
conclude that the physiological regulation of uncoupling by
UCP3 due to the lack of inhibition by nucleotides is di¡erent
from UCP1. In contrast, we believe that the uncoupling e¡ects
reported here and by others do not re£ect the normal function
of UCP3 in skeletal muscle. It is our working hypothesis that
the same criterion, inhibition by a low concentration of nu-
cleotide, which has been successfully used to de¢ne H trans-
port by UCP1 also applies to the physiological function of
UCP3.
With this presumption the observed results can be rational-
ised by assuming that UCP3 incorporated into the yeast mi-
tochondria primarily does not exist in the native but in a
deranged conformation unable to bind nucleotides. In this
state it forms an unregulated pore for fatty acid-independent
H transport in the inner membrane. Only a minor portion of
UCP3 is in a native conformation with a regulated H trans-
port. The conclusion gains support from the following facts.
(a) In the structure of UCP3 most of those residues are
present which have been identi¢ed in UCP1 to participate in
the nucleotide binding and in the pH regulation of binding.
(b) The short form UCP3s facilitates unregulated uncou-
pling as well as UCP3. The amputated protein with only
¢ve helices should be barely able to form a stable, functionally
competent conformation but rather exist in a deranged fold-
ing. The uncoupling seems to be weaker as judged from the
less retarded growth despite a nearly twice as high content. It
seems that in UCP3s also the unregulated H transport is
impaired.
(c) The unregulated uncoupling is highly variable, as ob-
served by comparing the uncoupling of human and murine
UCP3 in yeast cells. Subtle di¡erences in the amino acid com-
position may in£uence an unstable deranged conformation
more than a de¢nitive native conformation.
(d) UCP3 and UCP1 expressed in inclusion bodies of E. coli
and reconstituted into vesicles are able to catalyse a nucleo-
tide-sensitive Cl3 but not H transport [25]. The Cl3 trans-
port is inhibited by nucleotides with a KI6 1 WM for both
UCP3 and UCP1 and thus ful¢ls our ‘classical’ criterion [34]
for a UCP-catalysed function. The absence of H transport
was attributed to the lack of a cofactor in the reconstitution
from the inclusion bodies. The H transport activity by UCP3
reported recently by Jaburek et al. [26] does not contradict
our results, since the activity is about 40 times lower than with
native UCP1 accounting for the temperature di¡erence of
measurements. With a KI of 1 mM GTP it has a 104-fold
lower sensitivity to nucleotides than the Cl3 transport. In
Fig. 5. Recording of H e¥ux from mitochondria with a pH elec-
trode. Mitochondria containing hamster haUCP1 expressed with the
pEMBL Lyex4 vector and mitochondria containing human hUCP3
expressed with the pYES2 vector were used. The cells were induced
with 2% galactose after 15 h and harvested after another 10 h. The
calibration by addition of 1 nM H2SO4 is given at the left side. Mi-
tochondria (1.5 mg/ml) were incubated in a medium containing 0.6
M mannitol, 100 mM KCl, 2 mM KH2PO4 and 1 mM MOPS, pH
7.2. Electron transport was inhibited by 4 WM antimycin, and the
ADP/ATP carrier was blocked by 5 WM bongkrekate and 10 WM
carboxyatractylate. Further 50 WM LA was added and on addition
of 2 WM valinomycin (Va) H release was initiated. The total H
release capacity was measured after addition of 2 WM CCCP. In the
third experiment 100 WM GTP was added prior to the valinomycin.
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our own studies we have therefore regarded the same obser-
vation as non-speci¢c H leakage in the reconstituted vesicles.
Hinz et al. [21] argue that the conformation of UCP3 in our
reconstitution has an arti¢cially increased a⁄nity for nucleo-
tides. Such a reasoning would be opposite to the generally
accepted criterion that a more native folding of a protein
creates a function such as a speci¢c nucleotide binding site.
(e) Boss et al. [33] showed that overexpression of UCP3 in
myoblasts produces a much smaller downshift in FACS than
in yeast cells. Obviously on overexpression in natural mito-
chondria, UCP3 is in a native state where its uncoupling ca-
pacity is largely inhibited, i.e. regulated by internal nucleotides
and fatty acids.
We may ask why UCP1 but not UCP3 should attain the
native state on expression in yeast. The reason should exist in
the di¡erent structure. There is 57% similarity between the
two UCPs and the insertion into the yeast mitochondrial
membrane may critically depend on a good match between
the lipid environment and the protein. The phospholipid com-
position in yeast di¡ers by shorter fatty acids [35] and this
may be marginally tolerant to UCP1 but not any more to
UCP3. The nucleotide binding site seems to be most sensitive
to a disturbance of the native structure and thus loses its
competence in UCP3 expressed in yeast.
The practical consequences of these ¢ndings would be to
avoid the expression system in yeast for the characterisation
of UCP3 and, instead, to concentrate on the E. coli expression
system and there to explore conditions where UCP3 attains its
native capacity for H transport. Judged from the FACS
scans of UCP2-expressing yeast cells [18,19], it seems possible
that also UCP2 in yeast cells exists in a deranged conforma-
tion with similar consequences as for UCP3.
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